Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology
Albatroz Therapeutics works in Biotechnology, out of Singapore. Ownership is privately held; it publishes at albatroztherapeutics.com. It holds one address on record, all in Singapore. The record counts 7 people. Tagged cancer Therapeutics, arthritis Therapeutics and IBD Therapeutics. One Singapore registration (UEN) is a confirmed match. The latest round on record is Seed at US$3.0M. The record links seven similar brands, most of them in Biotechnology Research.
albatroztherapeutics.com LinkedIn
UEN202014947K
| ALBATROZ THERAPEUTICS PTE. LTD. | UEN 202014947K |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Albatroz Therapeutics is a pre-clinical stage biotech company developing therapeutic antibodies and ADCs to treat solid tumors and inflammatory diseases, based on its proprietary position over a novel target critical to the ECM degradation.
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
| Rounds | 1 |
|---|---|
| Axis | 2021 to 2026 |
| Seed · 25 May 2023 | US$ 3.0M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One Singapore entity on ACRA. ALBATROZ THERAPEUTICS PTE. LTD. (UEN 202014947K), high confidence.
The record holds 7 counted staff profiles at January 2026. Its self-reported band sits above that count and is not published as a headcount.
One address on record, Singapore only. Primary: 21 Biopolis Road, #02-03 Nucleos North Tower, Singapore 138567.
One round. Latest 25 May 2023: Seed, US$3,000,000, investors Outram Bio and Seeds Capital.
Six tags on the brand's own list, among them Cancer Therapeutics, Arthritis Therapeutics and IBD Therapeutics.
24 profiles list Albatroz Therapeutics as a peer — 96th percentile in Biotechnology. It lists ten peers of its own. Engine Biosciences and Allozymes list it back.